Literature DB >> 6356466

The mechanisms of action of ticlopidine.

J J Bruno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6356466     DOI： 10.1016/0049-3848(83)90359-6

Source DB:  PubMed          Journal:  Thromb Res Suppl        ISSN： 0896-0569


× No keyword cloud information.
  5 in total

Review 1.  Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

2.  Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

Authors:  T DiPerri; F L Pasini; C Frigerio; P Blardi; F Centini; G L Messa; A Ghezzi; L Volpi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 4.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Authors:  E Saltiel; A Ward
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 5.  Role of platelets in progressive glomerular diseases.

Authors:  C Zoja; G Remuzzi
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.